These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Naturally occurring persistent feline oncornavirus infections in the absence of disease. Essex M; Hardy WD; Cotter SM; Jakowski RM; Sliski A Infect Immun; 1975 Mar; 11(3):470-5. PubMed ID: 163793 [TBL] [Abstract][Full Text] [Related]
24. Comparison of three feline leukaemia virus (FeLV) point-of-care antigen test kits using blood and saliva. Westman ME; Malik R; Hall E; Sheehy PA; Norris JM Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():88-96. PubMed ID: 28131385 [TBL] [Abstract][Full Text] [Related]
25. No benefit of therapeutic vaccination in clinically healthy cats persistently infected with feline leukemia virus. Helfer-Hungerbuehler AK; Spiri AM; Riond B; Grest P; Boretti FS; Hofmann-Lehmann R Vaccine; 2015 Mar; 33(13):1578-85. PubMed ID: 25698488 [TBL] [Abstract][Full Text] [Related]
26. Circulating antibodies to the feline leukemia virus and FOCMA in cats. Lizonová A; Grófová M Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490 [TBL] [Abstract][Full Text] [Related]
27. Remission of FeLV-associated lymphosarcoma and persistent viral infection after extracorporeal immunoadsorption of plasma using staphylococcal protein A columns: details of immune response. Snyder HW; Reed DE; Jones FR Semin Hematol; 1989 Apr; 26(2 Suppl 1):25-30. PubMed ID: 2543084 [TBL] [Abstract][Full Text] [Related]
28. FeLV epidemiology in Los Angeles cats: Appraisal of detection methods. Gardner MB; Brown JC; Charman HP; Stephenson JR; Rongey RW; Hauser DE; Diegmann F; Howard E; Dworsky R; Gilden RV; Huebner RJ Int J Cancer; 1977 Apr; 19(4):581-9. PubMed ID: 191415 [TBL] [Abstract][Full Text] [Related]
29. Comparison of risk factors for seropositivity to feline immunodeficiency virus and feline leukemia virus among cats: a case-case study. Chhetri BK; Berke O; Pearl DL; Bienzle D BMC Vet Res; 2015 Feb; 11():30. PubMed ID: 25889006 [TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of protein A administered intravenously to pet cats with leukemia or lymphosarcoma. Harper HD; Sjöquist J; Hardy WD; Jones FR Cancer; 1985 May; 55(9):1863-7. PubMed ID: 2983866 [TBL] [Abstract][Full Text] [Related]
31. Sequence analysis of the putative viral enhancer in tissues from 33 cats with various feline leukemia virus-related diseases. Jackson ML; Haines DM; Misra V Vet Microbiol; 1996 Dec; 53(3-4):213-25. PubMed ID: 9008333 [TBL] [Abstract][Full Text] [Related]
32. Epidemiologic association between virus-negative feline leukemia and the horizontally transmitted feline leukemia virus. Francis DP; Essex M; Cotter SM; Gutensohn N; Jakowski R; Hardy WD Cancer Lett; 1981 Mar; 12(1-2):37-42. PubMed ID: 6268292 [TBL] [Abstract][Full Text] [Related]
33. Serological survey of Toxoplasma gondii, Dirofilaria immitis, Feline Immunodeficiency Virus (FIV) and Feline Leukemia Virus (FeLV) infections in pet cats in Bangkok and vicinities, Thailand. Sukhumavasi W; Bellosa ML; Lucio-Forster A; Liotta JL; Lee AC; Pornmingmas P; Chungpivat S; Mohammed HO; Lorentzen L; Dubey JP; Bowman DD Vet Parasitol; 2012 Aug; 188(1-2):25-30. PubMed ID: 22497870 [TBL] [Abstract][Full Text] [Related]
35. Ten-year study comparing enzyme-linked immunosorbent assay with the immunofluorescent antibody test for detection of feline leukemia virus infection in cats. Hardy WD; Zuckerman EE J Am Vet Med Assoc; 1991 Nov; 199(10):1365-73. PubMed ID: 1666084 [TBL] [Abstract][Full Text] [Related]
36. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70. Snyder HW; Singhal MC; Hardy WD; Jones FR J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496 [TBL] [Abstract][Full Text] [Related]
37. Prevention of the contagious spread of the feline leukemia virus between pet cats. Hardy WD; McClelland AJ; Zuckerman EE; Hess PW; Essex M; Cotter SM; MacEwen EG; Hayes AA Bibl Haematol; 1975 Oct; (43):511-4. PubMed ID: 183720 [No Abstract] [Full Text] [Related]
38. Long-term follow up of feline leukemia virus infection and characterization of viral RNA loads using molecular methods in tissues of cats with different infection outcomes. Helfer-Hungerbuehler AK; Widmer S; Kessler Y; Riond B; Boretti FS; Grest P; Lutz H; Hofmann-Lehmann R Virus Res; 2015 Feb; 197():137-50. PubMed ID: 25553598 [TBL] [Abstract][Full Text] [Related]
39. Tumorigenic potential of a myc-containing strain of feline leukemia virus in vivo in domestic cats. Levy LS; Fish RE; Baskin GB J Virol; 1988 Dec; 62(12):4770-3. PubMed ID: 2846887 [TBL] [Abstract][Full Text] [Related]
40. Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein. Stephenson JR; Essex M; Hino S; Hardy WD; Aaronson SA Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1219-23. PubMed ID: 191832 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]